Fortune reported on Tuesday, Nov. 16, that Dr. Mark Dybul, who is also the CEO of Enochian BioSciences, said he believes there is a "very high" probability that there will be a vaccine-resistant strain of COVID-19 by March, April, or May of 2022.
Dybul told the news outlet that therapeutic medications and other new products which are being developed will help reduce COVID-19 hospitalizations and transmission in the long term, but predicted that "the next year and a half could be pretty rough.”
Read the full report from Fortune here.
Click here to follow Daily Voice Amherst and receive free news updates.